Ardelyx

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.

About ARDX

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines.

CEO

Michael G. Raab

CEOMichael G. Raab

Employees

395

Employees395

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2007

Founded2007

Employees

395

Employees395

ARDX Key Statistics

Market cap

1.26B

Market cap1.26B

Price-Earnings ratio

-22.05

Price-Earnings ratio-22.05

Dividend yield

—

Dividend yield—

Average volume

5.39M

Average volume5.39M

High today

$5.25

High today$5.25

Low today

$5.10

Low today$5.10

Open price

$5.19

Open price$5.19

Volume

4.03M

Volume4.03M

52 Week high

$7.18

52 Week high$7.18

52 Week low

$3.21

52 Week low$3.21

ARDX News

Seeking Alpha 4d

Ardelyx raises 2025 IBSRELA revenue guidance to $250M–$260M amid sustained demand growth

Earnings Call Insights Ardelyx raises 2025 IBSRELA revenue guidance to $250M–$260M amid sustained demand growth Aug. 04, 2025 8:11 PM ET Ardelyx, Inc. (ARDX) St...

Analyst ratings

92%

of 12 ratings

Buy

91.7%

Hold

8.3%

Sell

People also own

Based on the portfolios of people who own ARDX. This list is generated using Robinhood data, and it’s not a recommendation.